Method for producing pancreatic β cells
A problem addressed by the present invention is to provide a method for producing pancreatic β cells from endothermal cells that have been induced to differentiate from pluripotent stem cells, wherein the method allows the production of pancreatic β cells of high quality, and to provide pancreatic progenitor (PP) cells, pancreatic endocrine precursor (EP) cells, and pancreatic β cells produced by the above-mentioned method. The present invention provides a method for producing pancreatic β cells that includes culturing primitive gut tube (PGT) cells, which have been induced to differentiate from pluripotent stem cells, in the presence of a protein kinase C (PKC) activator, thereby producing posterior foregut (PFG) cells; next culturing the cells in the presence of retinoic acid or an analog thereof, thereby producing pancreatic progenitor (PP) cells; next culturing the cells in the presence of a Notch signaling inhibitor and a ROCK signaling inhibitor, thereby producing pancreatic endocrine precursor (EP) cells; and next culturing the cells in the presence of an insulin receptor signaling activator, transferrin, and selenous acid, thereby producing pancreatic β cells.
1 . A method for producing pancreatic β cells comprising:
(a) a step of culturing primitive gut tube (PGT) cells, which have been induced to differentiate from pluripotent stem cells, in the presence of a protein kinase C (PKC) activator, thereby producing posterior foregut (PFC) cells;
(b) a step of culturing the posterior foregut (PFG) cells in the presence of retinoic acid or an analog thereof, thereby producing pancreatic progenitor (PP) cells;
(c) a step of culturing the pancreatic progenitor (PP) cells in the presence of a Notch signaling inhibitor and a ROCK signaling inhibitor, thereby producing pancreatic endocrine precursor (EP) cells; and
(d) a step of culturing the pancreatic endocrine precursor (EP) cells in the presence of an insulin receptor signaling activator, transferrin, and selenous acid, thereby producing pancreatic β cells,
wherein the step of culturing pancreatic progenitor (PP) cells in the presence of a Notch signaling inhibitor and a ROCK signaling inhibitor is a step of culturing the cells in a culture medium containing 0.0 mmol/L or more of nicotinamide.
2 . The method for producing pancreatic β cells according to claim 1 ,
wherein the step of culturing primitive gut tube (PGT) cells, which have been induced to differentiate from pluripotent stem cells, in the presence of a protein kinase C (PKC) activator is performed in the absence of FGF2.
3 . The method for producing pancreatic β cells according to claim 1 ,
wherein the step of culturing the pancreatic endocrine precursor (EP) cells in the presence of an insulin receptor signaling activator, transferrin, and selenous acid is performed in the absence of FGF2.
4 . The method according to claim 1 ,
wherein the primitive gut tube (PGT) cells, which have been induced to differentiate from pluripotent stem cells, are cells obtained by a step of culturing pluripotent stem cells under conditions in which the cells can be induced to differentiate to endodermal cells, and a step of culturing the cells under conditions in which the endodermal cells can be induced to differentiate to primitive gut tube (PGT) cells.
5 . The method according to claim 4 ,
wherein the step of culturing pluripotent stem cells under conditions in which the cells can be induced to differentiate to endodermal cells is a step of culturing the pluripotent stem cells in a culture medium containing a TGFβ superfamily signaling activator, and thereafter culturing the cells in a culture medium to which FGF2 and BMP4 are not added.
6 . The method according to claim 4 ,
wherein the step of culturing the cells under conditions in which the endodermal cells can be induced to differentiate to primitive gut tube (PGT) cells is a step of culturing the endodermal cells in the absence of a bone morphogenetic protein (BMP) signaling inhibitor.
7 . The method for producing pancreatic β cells according to claim 1 ,
wherein a step of culturing primitive gut tube (PGT) cells, which have been induced to differentiate from pluripotent stem cells, in the presence of a protein kinase C (PKC) activator is performed in the presence of a bone morphogenetic protein (BMP) signaling inhibitor.
8 . The method according to claim 7 ,
wherein the protein kinase C (PKC) activator is Indolactam V.
9 . The method according to claim 7 ,
wherein the bone morphogenetic protein (BMP) signaling inhibitor is LDN193189.
10 . The method according to claim 7 ,
wherein the protein kinase C (PKC) activator is Indolactam V and the bone morphogenetic protein (BMP) signaling inhibitor is LDN193189.